Antibiotics/antineoplansticsLack of efficacy and posterior reversible encephalopathy syndrome: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2041卷 / 1期

关键词：

D O I：

10.1007/s40278-025-74430-3

中图分类号：

学科分类号：

摘要：

引用

页码：41 / 41

共 50 条

[31] MesalazineFirst report of posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2014, 1498 (1) : 20 - 20
[32] DuloxetineFirst report of posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2016, 1622 (1) : 86 - 86
[33] Metandienone/metenoloneHypertensive encephalopathy and posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2016, 1611 (1) : 120 - 120
[34] AripiprazoleNeuroleptic malignant syndrome and posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2013, 1441 (1) : 8 - 8
[35] Dihydroergotamine mesilateFirst report of posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2008, 1208 (1) : 12 - 12
[36] Clonazepam withdrawalFirst report of posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2016, 1607 (1) : 122 - 122
[37] Posterior reversible encephalopathy syndrome: a report of a case with atypical features
Pratap, J. N.
Down, J. F.
ANAESTHESIA, 2008, 63 (11) : 1245 - 1248
[38] Gemcitabine/oxaliplatinDelayed posterior reversible encephalopathy syndrome: case report
Reactions Weekly, 2007, 1162 (1) : 17 - 17
[39] Posterior Reversible Encephalopathy Syndrome with Obstructive Hydrocephalus A Case Report
Wirojtananugoon, C.
Laothamatas, J.
NEURORADIOLOGY JOURNAL, 2011, 24 (02): : 258 - 263
[40] A CASE REPORT ON POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME SECONDARY TO THYROTOXICOSIS
Aragon, Daniel
Patel, Namita
Okwechime, Remi
CRITICAL CARE MEDICINE, 2024, 52

← 1 2 3 4 5 →